Bioventus Market Cap

Bioventus has a market cap or net worth of $263.02 million as of April 24, 2024. Its market cap has increased by 220.76% in one year.

Market Cap

263.02M

Enterprise Value

620.90M

1-Year Change

220.76%

Ranking

#3437

Market Cap Chart

Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $263.02M, a decrease of -63.13%. That is a compound annual growth rate of -26.81%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	341.20M	0.47%
Apr 22, 2024	339.60M	-4.26%
Apr 19, 2024	354.70M	-1.53%
Apr 18, 2024	360.20M	-3.20%
Apr 17, 2024	372.10M	1.31%
Apr 16, 2024	367.30M	0.22%
Apr 15, 2024	366.50M	1.30%
Apr 12, 2024	361.80M	-4.99%
Apr 11, 2024	380.80M	-3.23%
Apr 10, 2024	393.50M	-1.77%
Apr 9, 2024	400.60M	-2.88%
Apr 8, 2024	412.50M	2.97%
Apr 5, 2024	400.60M	2.64%
Apr 4, 2024	390.30M	-1.79%
Apr 3, 2024	397.40M	-0.40%
Apr 2, 2024	399.00M	-3.44%
Apr 1, 2024	413.20M	0.36%
Mar 28, 2024	411.70M	0.78%
Mar 27, 2024	408.50M	0.39%
Mar 26, 2024	406.90M	0.20%
Mar 25, 2024	406.10M	-5.71%
Mar 22, 2024	430.70M	0.19%
Mar 21, 2024	429.90M	-5.56%
Mar 20, 2024	455.20M	6.48%
Mar 19, 2024	427.50M	-1.63%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
RAPT Therapeutics	278.38M
Opthea	278.38M
Enanta Pharmaceuticals	278.20M
Monte Rosa Therapeutics	277.85M
Werewolf Therapeutics	275.23M
Inozyme Pharma	271.80M
Tevogen Bio Holdings	271.61M
Invivyd	270.63M

Market Cap Rankings